A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.

Kisspeptin 1mg/mL
Investigational Hypothalamic Signaling Peptide


Compound Specifications
Kisspeptin 1mg/mL
Investigational Hypothalamic Signaling Peptide
Kisspeptin is a neuropeptide investigated in scientific research for its potential role as an upstream signaling molecule within the hypothalamic-pituitary-gonadal (HPG) axis, with preclinical studies exploring its interactions with GnRH, LH, and FSH pathways. This is an investigational compound; these statements have not been evaluated by the FDA and it is not intended to diagnose, treat, cure, or prevent disease.
In laboratory research, kisspeptin has been studied for potential binding to KISS1R (GPR54) receptors in the hypothalamus and interactions with gonadotropin-releasing hormone (GnRH) signaling pathways. Results may vary; individual outcomes depend on baseline health, adherence, and other factors.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Subcutaneous injection as prescribed.
Frequently Asked Clinical Questions
Can Kisspeptin help restart natural testosterone?
Preclinical research has explored kisspeptin for potential interactions with hypothalamic signaling pathways that may influence downstream LH and FSH. This is investigational research only; results may vary and individual outcomes depend on baseline health and other factors. Consult your primary care physician.
